CompletedNot Applicable

Effect of NB-UVB on the Tissue Level of IL 15 and IL-15Rα in Active Non Segmental Vitiligo Cases.

Egypt30 participantsStarted 2022-04-30

Plain-language summary

This study aims at evaluating the effect of NB-UVB on tissue level of IL-15 and IL-15 receptor alpha subunit (IL-15Rα)(CD215) in active non segmental vitiligo. This in turn will shed light on the potential role of phototherapy as a safe mean of prevention of vitiligo recurrence as well as evaluating the utility of IL 15 and IL 15 Rα as markers of vitiligo activity/recurrence.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Age: ≥ 18 years. * Both genders. * Type of Vitiligo: non segmental vitiligo (NSV). * Active disease for less than 6 months (VIDA ≥ +2). * No systemic or topical treatment for vitiligo for at least one month. Exclusion criteria: * Patients less than 18 years. * VIDA ≤ +1. * Contraindications to phototherapy (precancerous conditions like * Xeroderma pigmentosum , photosensitivity, history of arsenic intake, * ionizing radiation, extensive previous exposure to PUVA, patients * with a history of melanoma, atypical nevi, non-melanoma skin * cancers and patients taking immunosuppressive medications ( Menter et al., 2010 and Mehta \& Lim, 2016). * Pregnancy and lactation . * Patients who received systemic or topical treatment for the past * month. * patients having any autoimmune diseases .

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Effect of NB-UVB on tissue level of IL 15 and IL15Rα in active vitiligo

Timeframe: 4 month

Trial details

NCT IDNCT05316987

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07-30

View on ClinicalTrials.gov More Active Non Segmental Vitiligo trials